問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
未分科
下載
2022-04-05 - 2024-09-30
Condition/Disease
Test Drug
Participate Sites5Sites
Not yet recruiting4Sites
Terminated1Sites
2022-07-01 - 2025-03-14
Participate Sites9Sites
Terminated9Sites
2021-02-01 - 2023-12-31
Not yet recruiting5Sites
2019-01-01 - 2028-12-31
Participate Sites7Sites
Recruiting7Sites
2020-06-01 - 2024-04-30
Participate Sites3Sites
Recruiting3Sites
2018-11-01 - 2021-12-31
Lupus Nephritis
Orelvo (voclosporin)
Participate Sites4Sites
Terminated2Sites
Division of Rheumatology
2017-02-01 - 2019-05-09
Atrial Fibrillation Following Successful Percutaneous Coronary Intervention (PCI) With Stent Placement
Edoxaban (DU-176b)
Participate Sites13Sites
Terminated11Sites
Division of Cardiovascular Diseases
2019-06-01 - 2023-02-09
Paroxysmal Nocturnal Hemoglobinuria
eculizumab (SB12 or EU sourced Soliris)
2018-03-01 - 2022-12-13
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Nivolumab
Not yet recruiting1Sites
Terminated3Sites
2020-02-01 - 2023-12-15
Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
ION-682884 Injection; Inotersen (ISIS 420915) Injection
Recruiting4Sites
全部
